| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-30 |
4 |
S |
$54.71 |
$8,473,790 |
D/D |
(154,887) |
224,359 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
175,000 |
552,546 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2019-01-18 |
4 |
B |
$5.37 |
$1,024,999 |
I/I |
190,875 |
3,994,781 |
2.64 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2012-06-30 |
4 |
D |
$7.40 |
$1,463,454 |
D/D |
(197,764) |
432,263 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-04-02 |
4 |
S |
$13.46 |
$2,720,111 |
D/D |
(202,090) |
189,486 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
260,528 |
321,162 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-29 |
4 |
OE |
$4.41 |
$2,216,615 |
D/D |
270,625 |
525,616 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-29 |
4 |
S |
$51.01 |
$20,405,120 |
D/D |
(400,000) |
379,246 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-09-17 |
4 |
AS |
$9.40 |
$3,760,000 |
I/I |
(400,000) |
2,600,980 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
460,000 |
682,277 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-04-29 |
4 |
OE |
$4.41 |
$3,543,959 |
D/D |
542,928 |
544,764 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-04-29 |
4 |
S |
$24.92 |
$14,952,360 |
D/D |
(600,000) |
486,536 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-12-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(993,801) |
3,000,980 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-05-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,627,157) |
0 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,878,441 |
3,803,906 |
0 |
- |
|
140 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
